Related Experiment Video
Updated: Jun 12, 2026

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries
Published on: February 25, 2016
Arginase 2 and nitric oxide synthase: Pathways associated with the pathogenesis of thyroid tumors
Maria Sharmila A Sousa1, Flavia R M Latini, Hugo P Monteiro
1Genetic Basis of Thyroid Tumors Laboratory, Division of Genetics, Department of Morphology and Genetics, Federal University of São Paulo, 04039-032 São Paulo, SP, Brazil.
Abstract:
We have previously shown that ARG2 expression was increased in most malignant thyroid tumors, but absent in benign lesions and normal tissues. Small interfering RNA knockdown was used to investigate the role of ARG2 in a thyroid carcinoma cell line. ARG2 knockdown decreased eNOS expression as well as the expression of eNOS-related genes (p21, Akt1, HIF-1, VEGF, and CAV1). ARG2 silencing changed tumor properties of thyroid cancer cells promoting apoptosis and reduced expression of cell proliferation markers. These results, coupled with enhanced nitric oxide production and elevated reactive oxygen species (ROS) levels, account for the altered intracellular redox environment. Genes related to either production (DUOX1 and NOX4) or catabolism (SODs) of ROS and reactive nitrogen species were negatively modulated by ARG2 knockdown. Additionally, a positive correlation of ARG2 with eNOS and related genes was investigated in thyroid tumors, further substantiating our in vitro findings. Our results suggest that ARG2 and eNOS may work in a coordinated manner and the underlying mechanism might be of major significance for thyroid tumorigenesis and/or tumor progression pathways. Fine modulation of ARG2, eNOS, and related genes may represent a potential source for targeted therapy of several cancer types.
Insights
Arginase 2 (ARG2) promotes thyroid cancer by increasing eNOS expression and altering the cellular redox environment. Targeting ARG2 may offer a novel therapeutic strategy for thyroid tumors.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Arginase 2 (ARG2) expression is elevated in malignant thyroid tumors but absent in normal tissues and benign lesions.
- Understanding ARG2's role is crucial for identifying new therapeutic targets in thyroid cancer.
Purpose of the Study:
- To investigate the functional role of ARG2 in thyroid carcinoma.
- To elucidate the molecular mechanisms by which ARG2 influences tumor properties and intracellular environment.
Main Methods:
- Small interfering RNA (siRNA) knockdown of ARG2 in a thyroid carcinoma cell line.
- Analysis of eNOS and related gene expression (p21, Akt1, HIF-1, VEGF, CAV1).
- Assessment of cellular properties including apoptosis and proliferation markers, nitric oxide (NO) production, and reactive oxygen species (ROS) levels.
Main Results:
- ARG2 knockdown reduced eNOS and related gene expression, suppressed cell proliferation, and promoted apoptosis.
- Silencing ARG2 altered the intracellular redox balance, affecting nitric oxide and ROS levels.
- Genes involved in ROS/reactive nitrogen species metabolism (DUOX1, NOX4, SODs) were modulated by ARG2 knockdown.
- A positive correlation between ARG2, eNOS, and related genes was observed in thyroid tumors.
Conclusions:
- ARG2 and eNOS likely function coordinately in thyroid tumorigenesis and progression.
- ARG2 plays a significant role in modulating the tumor microenvironment and cellular behavior.
- Targeting ARG2 and eNOS pathways presents a potential therapeutic avenue for thyroid cancer.
Related Concept Videos
Hyperthyroidism II: Pathophysiology
Nitric Oxide Signaling Pathway
Hypothyroidism II: Pathophysiology
Graves Disease II: Pathophysiology
2° Amines to N-Nitrosamines: Reaction with NaNO2
Synthesis and Regulation of Thyroid Hormones
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...

